Mapi Pharma to Present New Safety and Efficacy Data from Glatiramer Acetate Depot Long-Acting Injection Phase II Study in Patients with Primary Progressive Multiple Sclerosis ...

GA Depot is a long-acting injection version of the approved Glatiramer Acetate (GA, commercially available as Copaxone ® /Glatopa ® ). PPMS is characterized by continued worsening neurologic function ...
Ars Technica

Exchange: So what constitutes a MAPI session, anyway?

I run two separate Exchange environments for two different organizations. In both (Exchange 2010 and 2013, both fully patched to current), I get the occasion Event 9646 entry for clients that have ...
Business Insider

Mapi Pharma to Build a New Sterile Injectable Production Plant for GA Depot in Jerusalem

NESS ZIONA, Israel, July 15, 2019 (GLOBE NEWSWIRE) -- Mapi Pharma Ltd., a fully integrated, late-stage clinical development biopharmaceutical company announced today that is has signed a long term ...
FiercePharma

Israel's Mapi Pharma sets aside manufacturing space to boost country's COVID-19 jab supply

With the end of the year fast approaching, nations are looking for ways to secure enough supply of a potential COVID-19 vaccine to meet demand from their citizens. For Israeli drugmaker Mapi Pharma, ...
FierceBiotech

Mapi Pharma makes third attempt to list on Nasdaq

Mapi Pharma is nothing if not persistent. Having tried and failed twice to pull off an IPO on Nasdaq, the Israeli biopharma has arrived on Wall Street yet again in pursuit of $57.5 million (€51.2 ...